Rhabdomyosarcoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Clinical Trials

Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials
Condition:   Rhabdomyosarcoma Intervention:   Sponsor:   Power Life Sciences Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
Condition:   Rhabdomyosarcoma Interventions:   Drug: Vincristine;   Drug: Dactinomycin;   Drug: Cyclophosphamide;   Procedure: Surgical Resection;   Procedure: Proton beam radiation or external beam radiation or brachytherapy;   Drug: Liposomal irinotecan;   Drug: Vinorelbine;   Drug: Temozolomide;   Drug: Filgrastim, peg- filgrastim Sponsor:   St. Jude Children's Research Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2023 Category: Research Source Type: clinical trials